Earlier this week Microsoft Billionaire, Bill Gates, announced that he would be donating $100 million of his own personal money to Alzheimer’s research.

$50 million will go to UK-based Dementia Discovery Fund, a venture capital fund that brings together industry and government to seek treatments for the brain-wasting disease.

The Dementia Discovery Fund, which was launched in 2015 and involves drugmakers GlaxoSmithKline, Johnson & Johnson, Eli Lilly, Pfizer and Biogen Idec as well as the UK government.

This will be followed by another $50 million that will go to start-up ventures working in Alzheimer’s research

Gates made the announcement on his blog, in a post titled “Why I’m Digging Deep Into Alzheimer’s

“Your risk of getting arthritis, Parkinson’s, or another non-infectious disease that diminishes your quality of life increases with each year. But of all the disorders that plague us late in life, one stands out as a particularly big threat to society: Alzheimer’s disease,” he said.

“It’s a huge problem, a growing problem, and the scale of the tragedy—even for the people who stay alive—is very high”.

“The human cost of Alzheimer’s is much more difficult to put into numbers. It’s a terrible disease that devastates both those who have it and their loved ones.”

“This is something I know a lot about, because men in my family have suffered from Alzheimer’s. I know how awful it is to watch people you love struggle as the disease robs them of their mental capacity, and there is nothing you can do about it.”

Though Gates explains that his experience isn’t his only motivation, “my family history isn’t the sole reason behind my interest in Alzheimer’s. But my personal experience has exposed me to how hopeless it feels when you or a loved one gets the disease.”

“We’ve seen scientific innovation turn once-guaranteed killers like HIV into chronic illnesses that can be held in check with medication. I believe we can do the same (or better) with Alzheimer’s.”

“I hope that in the next 10 years that we have some powerful drugs, but it’s possible that won’t be achieved.”

Though his work and learnings with researchers, academics, funders, and industry experts, Gates believes there are five key areas of progress;

  1. We need to better understand how Alzheimer’s unfold
  2. We need to detect and diagnose Alzheimer’s earlier
  3. We need more approaches to stopping the disease
  4. We need to make it easier to get people enrolled in clinical trials
  5. We need to use data better

In addition to the $100 million, Gates said that we would like to see a global dementia data platform – and that he was willing to award a grant to anyone willing to build it.

Such a platform would help researched look up previous data and see if there are patterns or new potential pathways for treatment.

What do you have to say? Comment, share and like below.

(Visited 240 times, 1 visits today)